Heart imaging test comparison for patients getting a new heart valve
Part of Heart & circulation clinical trials.
This study compares two heart imaging scans to see if a newer CT scan works as well as an MRI for checking blood flow and heart tissue in people having a heart valve replacement. It may help improve care for patients with aortic stenosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 60 or older
- Planning to have a heart valve replacement procedure (TAVI)
- Need a CT scan as part of the pre-procedure planning
- Must not have irregular heart rhythms like atrial fibrillation
- Must not have severe heart failure (NYHA class IV)
- Must not have kidney problems or allergies to contrast dye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two heart imaging tests (SPECT and coronary CTA) to see if a newer method gives a clearer picture of blood flow. If you have been referred for one of these tests, you may be able to help by also having the other test done at no extra risk.
This trial tests if a heart imaging scan (myocardial perfusion) can help doctors better diagnose heart attacks or other conditions in people who come to the hospital with chest pain but without ST elevation on their ECG. It aims to see if the scan adds valuable information before heart catheterization.
This study checks whether special heart tests can better understand “in-between” blocked heart arteries before and after TAVI (a valve replacement done through a catheter). It may help doctors choose the safest, most accurate treatment when coronary artery disease is unclear.
This study uses a CT scan (with contrast dye) to measure the coronary artery openings after people have a new aortic valve placed surgically. It aims to see how to best plan or understand coronary blood flow after the surgery.
This Phase 2 trial uses a PET scan to study how local inflammation inside the heart affects the heart’s electrical wiring after a minimally invasive aortic valve procedure. The results may help doctors better predict or prevent rhythm and conduction problems after treatment.
This trial compares two strategies for deciding which heart blockages to treat, using special pressure and blood-flow measurements during a heart procedure. It may help doctors choose more accurate treatment by tailoring the plan to each person’s heart blood flow.
Hear when a new Myocardial Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.